Analyst Ratings For Adaptive Biotechnologies Corp (NASDAQ:ADPT)
Today, Cowen initiated coverage on Adaptive Biotechnologies Corp (NASDAQ:ADPT) with a Outperform.
There are 4 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on Adaptive Biotechnologies Corp (NASDAQ:ADPT) is Buy with a consensus target price of N/A per share, a potential N/A.
Some recent analyst ratings include
- 7/22/2019-Adaptive Biotechnologies Corp (NASDAQ:ADPT) has coverage initiated with a Outperform rating
- 7/22/2019-Adaptive Biotechnologies Corp (NASDAQ:ADPT) has coverage initiated with a Buy rating
- 7/22/2019-Adaptive Biotechnologies Corp (NASDAQ:ADPT) has coverage initiated with a Buy rating
- 7/22/2019-Adaptive Biotechnologies Corp (NASDAQ:ADPT) has coverage initiated with a Overweight rating
- 7/22/2019-Adaptive Biotechnologies Corp (NASDAQ:ADPT) has coverage initiated with a Neutral rating
Recent Trading Activity for Adaptive Biotechnologies Corp (NASDAQ:ADPT)
Shares of Adaptive Biotechnologies Corp closed the previous trading session at 38.53 up +0.52 1.37% with shares trading hands.